Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT03658330

Organisation Name: VA Connecticut Healthcare System

Overal Status: Completed

Start Date: May 2016

Last Update: September 7, 2018

Lead Sponsor: VA Connecticut Healthcare System

Brief Summary: To evaluate if naltrexone plus ketamine is effective in reducing depression and alcohol consumption.

Conditions:
  • Major Depressive Disorder
  • Alcohol Use Disorder


Total execution time in seconds: 0.21165800094604